Table 1.
Participant Characteristics | % (n)* |
---|---|
Gender | |
Male | 63% (163) |
Female | 37% (96) |
Age Range | |
30–40 | 52% (134) |
41–50 | 30% (78) |
51–60 | 12% (32) |
>60 | 6% (15) |
Time of Survey Completion | |
October 2020 | 44% (114) |
November 2020 | 38% (99) |
December 2020 | 18% (46) |
Current Living Arrangements | |
Alone | 11% (28) |
With children | 65% (169) |
With elderly people | 5% (13) |
US Region | |
South | 26% (65) |
Northeast | 15% (39) |
Midwest | 21% (53) |
West | 38% (96) |
COVID-19’s Impact on Mental Health | |
No negative impact | 15% (39) |
Small negative impact | 41% (104) |
Moderate negative impact | 32% (81) |
Large negative impact | 12.5% (32) |
Depression Severity; median (IQR) | 8 (4–12) |
Minimal | 50.5% (129) |
Mild | 36.5% (93) |
Moderate | 7% (18) |
Moderate to severe | 5% (13) |
Severe | 1% (2) |
Anxiety Severity; median (IQR) | 4 (2–8) |
Minimal | 54.5% (139) |
Mild | 32.5% (83) |
Moderate | 9% (23) |
Severe | 4% (10) |
Insomnia Severity; median (IQR) | 4 (1–7) |
None | 49% (123) |
Subthreshold insomnia | 36.45% (92) |
Clinical insomnia (moderate) | 13.5% (34) |
Clinical insomnia (severe) | 1% (3) |
PTSD (specific to COVID-19) | |
No PTSD | 92.5% (236) |
PTSD criteria met | 7.5% (19) |
Obsession with COVID-19 | |
No problematic thinking related to COVID-19 | 87.5% (210) |
Problematic thinking related to COVID-19 | 12.5% (30) |
US, United States; COVID-19, coronavirus disease 2019; IQR, interquartile range.
PTSD, post-traumatic stress disorder.